Chronic non-viral hepatitis

Published on 08/04/2015 by admin

Filed under Gastroenterology and Hepatology

Last modified 08/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2548 times

Chapter 38 CHRONIC NON-VIRAL HEPATITIS

KEY POINTS

• Chronic non-viral hepatitis is a clinicopathologic liver syndrome most commonly due to autoimmune hepatitis.
• Other causes include cryptogenic hepatitis, and drug or toxin-induced hepatitis.
• Autoimmune hepatitis is characterised by the presence of smooth muscle antibodies, antinuclear antibodies and hypergammaglobulinaemia, and histologically by the presence of interface hepatitis and lymphoplasmacytic infiltrate.
• Key management objectives are to establish the cause and degree of hepatic inflammation and fibrosis.
• Corticosteroids alone or in combination with azathioprine are the treatment of choice for autoimmune hepatitis and may play a role in cryptogenic hepatitis and select cases of drug-induced hepatitis.

INTRODUCTION

Chronic non-viral hepatitis is a clinicopathological liver syndrome due to causes other than chronic viral infection. The most common causes are autoimmune hepatitis, cryptogenic hepatitis and drug or toxin-induced hepatitis. Symptoms are typically non-specific and include fatigue, malaise and right upper quadrant discomfort. Signs of chronic liver disease, hepatosplenomegaly and portal hypertension may be present. The most important histologic feature is interface hepatitis with piecemeal necrosis in the periportal region. Autoimmune hepatitis is the most important differential diagnosis.

Definition

Chronic non-viral hepatitis is a disease of the liver characterised by chronic inflammation and liver cell necrosis, that is due to non-viral causes and which persists without improvement for at least 6 months. However, in autoimmune hepatitis, the 6- month requirement is no longer required to establish chronicity as the condition may present acutely. Also, drug or toxin-induced liver disease is sometimes considered a chronic disease when the duration of liver inflammation extends beyond 3 months.

CAUSES

The causes of non-viral chronic hepatitis are listed in Table 38.1. The principal cause is autoimmune hepatitis. Less common causes include drug-induced hepatitis and cryptogenic hepatitis. The hereditary metabolic liver diseases, Wilson’s disease and alpha1-antitrypsin deficiency, may also cause a chronic hepatitis-like picture. Diseases mimicking chronic hepatitis include non-alcoholic steatohepatitis, sclerosing cholangitis and primary biliary cirrhosis.

TABLE 38.1 Non-viral causes of chronic hepatitis

Cause Specific histology
Autoimmune hepatitis Interface and lobular hepatitis, plasma cell and lymphocytic infiltrate, rosette formation, bridging and confluent necrosis
Drugs and toxins Similar to chronic viral hepatitis; may be autoimmune hepatitis-like; ± eosinophils; ± granulomas
Cryptogenic Similar to autoimmune hepatitis
Wilson’s disease Copper deposits
Alpha1-antitrypsin deficiency Eosinophilic globules in periportal zones

Autoimmune hepatitis

Autoimmune hepatitis (AIH) accounts for about 20% of cases of chronic hepatitis. The disease has a female preponderance, affects all ages and has a worldwide distribution. There is a genetic association with the human leucocyte antigens B8, DR3 and DR4. The cause of AIH is unknown. Autoantibodies including antinuclear antibody (ANA) and anti-smooth muscle antibody (SMA) are very common but not specific for the disease or of pathogenetic significance. At least two types of AIH are recognised.

Type 1 AIH is the most common form representing 80% of cases. It is characterised by the presence of ANA and/or SMA and hypergammaglobulinaemia. The peak incidence occurs between the ages of 16 and 30 years, with 70% being females younger than 40 years. Around 30%–50% of patients have concurrent immune diseases including ulcerative colitis, autoimmune thyroiditis and synovitis. The clinical course is often indolent. Symptoms may start abruptly in 40% of patients, but an acute fulminant presentation occurs rarely. Cirrhosis may be present at diagnosis in 25% of cases.

Type 2 AIH is a rare disorder that predominantly affects children aged between 2 and 14 years. It is characterised by the presence of antibodies to liver-kidney microsome type 1 (anti-LKM-1). The target autoantigen is the drug metabolising enzyme, cytochrome mono-oxygenase P450 IID6 (CYP2D6). Extrahepatic immune diseases occur more commonly than in type 1 AIH. There is an association with autoimmune polyglandular syndrome type 1. The clinical course is more aggressive than type 1 AIH with a higher frequency of progression to cirrhosis.

Drug-induced hepatitis

Drugs associated with inducing hepatitis are listed in Table 38.2. For more information on drug-induced hepatotoxicity, see Chapter 41.

TABLE 38.2 Drugs reported to cause chronic hepatitis

• Paracetamol
• Dantrolene
• Diclofenac
• Isoniazid
• Lisinopril
• Methyldopa

• Minocycline
• Nitrofurantoin
• Papaverine
• Perhexilene
• Propylthiouracil
• Sulfonamides

Cryptogenic hepatitis

Around 10%–20% of patients with chronic hepatitis have no definable cause and are classified as cryptogenic hepatitis. It is a diagnosis of exclusion. It may be due to an unknown virus, burnt-out non-alcoholic steatohepatitis or an autoimmune process. The condition may clinically resemble type 1 AIH in age and sex distribution, necroinflammatory activity, HLA status and response to therapy.

Inherited metabolic liver diseases

Wilson’s disease may cause chronic hepatitis in about 5%–30% of patients. Liver inflammation typically manifests in older children, and adults under the age of 35 years. Chronic hepatitis is an uncommon manifestation of alpha1-antitrypsin deficiency. It occurs in both children and adults and is usually mild. Globular eosinophilic deposits in the cytoplasm of hepatocytes on haematoxylin and eosin (H&E) or periodic acid-Schiff (PAS) staining after diastase are characteristic of the disease.

CLINICAL FEATURES

General

Chronic non-viral hepatitis may present with asymptomatic liver function test abnormalities, non-specific symptoms or overt manifestations of liver failure.

Autoimmune hepatitis

The clinical features of severe AIH are shown in Table 38.3. An acute onset is observed in about 25% of patients. Fulminant hepatitis occurs rarely. Common extrahepatic associations are autoimmune thyroid disease, ulcerative colitis and synovitis.

TABLE 38.3 Clinical features of severe autoimmune hepatitis

Clinical features at presentation Frequency (%)
Symptoms  
• Fatigue and loss of energy 85
• Dark urine and/or light stools 77
• Abdominal pain/discomfort 48
• Anorexia, nausea 30
• Pruritus 36
• Polymyalgias 30
• Diarrhoea 28
• Amenorrhoea (women) 89
• Cosmetic changes (facial rounding, hirsutism, acne) 19

Clinical signs   • Hepatomegaly 78 • Spider naevi 58 • Palpable spleen 32–56 • Scleral icterus/jaundice 46 • Ascites 20 • Encephalopathy 16

Diagnostic approach

The key objectives in the assessment of chronic hepatitis are to establish:

• the cause
• degree of hepatic necroinflammation and fibrosis
Buy Membership for Gastroenterology and Hepatology Category to continue reading. Learn more here

Related posts:

Alcoholic liver disease Acute abdominal pain Chronic pancreatitis Suspected iron overload or high serum ferritin Medical problems after liver transplantation The hepatitis B-positive patient